United States Biological Safety Testing Market Size, Share, Analysis | Top Companies - Avance Biosciences, Cytovance Biologics, Eurofins Scientific

"Biological Safety Testing Market is expected to reach at a CAGR of 5.1% during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/biological-safety-testing-market?sp

United States: Recent Industry Developments

✅ In September 2025, Charles River Laboratories launched a new high-throughput biological safety testing platform for vaccine development. The system integrates advanced automation and AI-driven analytics to accelerate testing timelines. It aims to support faster, more reliable evaluation of biologics and vaccines.

✅ In August 2025, Thermo Fisher Scientific received FDA approval for its next-generation in vitro safety testing kit designed for biologic therapeutics. The kit enables precise detection of potential cytotoxicity and immunogenic responses. This approval strengthens the company's position in preclinical safety testing.

✅ In July 2025, a U.S. biotech startup introduced a rapid microbial detection assay for biologics, reducing turnaround times for sterility and endotoxin testing. The assay is designed to improve quality control in manufacturing and research laboratories.

✅ In June 2025, the FDA issued updated guidance on biological safety testing for cell and gene therapies. The guidance outlines regulatory expectations for risk assessment, ensuring patient safety while facilitating innovation in biologic development.

Japan: Recent Industry Developments

✅ In September 2025, Japan's National Institute of Infectious Diseases unveiled an advanced biological safety testing platform for high-risk pathogens. The platform allows real-time monitoring and precise hazard assessment for emerging infectious diseases.

✅ In August 2025, a Japanese biotech company launched a fully automated testing system for biologic therapeutics, integrating pathogen detection and cytotoxicity analysis. The system is aimed at accelerating preclinical safety testing workflows.

✅ In July 2025, Japan's Ministry of Health, Labour and Welfare approved a novel in vitro assay kit for evaluating immunogenicity of biologic products. The approval provides a faster, reliable method for assessing therapeutic safety.

✅ In June 2025, researchers in Japan developed a microbial and enzymatic testing method to detect contaminants in complex biologic formulations. The method is being piloted with pharmaceutical companies to improve accuracy and compliance in safety testing.

Biological Safety Testing Market: Drivers

The biological safety testing market is witnessing rapid growth due to increasing demand for safe, high-quality, and regulatory-compliant products in pharmaceuticals, biotechnology, medical devices, and food industries. Biological safety testing involves evaluating products for cytotoxicity, microbial contamination, genotoxicity, and immunogenicity to ensure they are safe for human use and meet global regulatory standards. Technological advancements in in vitro testing, high-throughput screening, molecular assays, and automation are enhancing testing accuracy, reproducibility, and efficiency. Rising adoption of biologics, vaccines, and advanced medical devices is driving market expansion. Growing regulatory oversight, stringent quality control requirements, and emphasis on patient safety are further fueling demand for biological safety testing solutions.

Integration of biological safety testing with digital lab management systems, AI-driven data analysis, and predictive modeling is enabling faster decision-making, streamlined workflows, and improved compliance. Collaborations between contract testing laboratories, pharmaceutical companies, and research institutions are fostering innovation in high-precision, reliable, and standardized testing protocols. Expansion of biopharmaceutical development, regenerative medicine, and personalized therapies is creating additional market opportunities. Regulatory frameworks, international standards, and certification requirements are encouraging broader adoption of advanced safety testing solutions. Overall, technological innovation, rising biologics production, and stringent safety regulations are driving sustained growth in the global biological safety testing market.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biological-safety-testing-market?sp

Biological Safety Testing Market: Major Players

Avance Biosciences, Cytovance Biologics, Eurofins Scientific, Lonza, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Toxikon, and WuXi AppTec, Charles River Laboratories among others.

Segment Covered in the Biological Safety Testing Market:

➥ By Product: Reagents and Kits, Instruments, Other Products

➥ By Application: Vaccines and Therapeutics, Cellular and Gene Therapy, Blood and Blood-based Therapy, Other Applications

➥ By Test: Bioburden Tests, Sterility Tests, Endotoxin Tests, Other Tests

Research Process:

Both primary and secondary data sources have been used in the Biological Safety Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Biological Safety Testing Market Research Industry:

➠ Who leads the Biological Safety Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Biological Safety Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Biological Safety Testing market growth?
➠ What are the dominant sales and distribution strategies in the Biological Safety Testing industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biological-safety-testing-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.